» Articles » PMID: 27079684

Genome-wide Association Studies and Epigenome-wide Association Studies Go Together in Cancer Control

Overview
Journal Future Oncol
Specialty Oncology
Date 2016 Apr 16
PMID 27079684
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Completion of the human genome a decade ago laid the foundation for: using genetic information in assessing risk to identify individuals and populations that are likely to develop cancer, and designing treatments based on a person's genetic profiling (precision medicine). Genome-wide association studies (GWAS) completed during the past few years have identified risk-associated single nucleotide polymorphisms that can be used as screening tools in epidemiologic studies of a variety of tumor types. This led to the conduct of epigenome-wide association studies (EWAS). This article discusses the current status, challenges and research opportunities in GWAS and EWAS. Information gained from GWAS and EWAS has potential applications in cancer control and treatment.

Citing Articles

The Interaction between CLSPN Gene Polymorphisms and Alcohol Consumption Contributes to Oral Cancer Progression.

Hsieh M, Lo Y, Ho H, Lin C, Chuang Y, Chen M Int J Mol Sci. 2024; 25(2).

PMID: 38256171 PMC: 10816373. DOI: 10.3390/ijms25021098.


Epigenetic Profiling of Type 2 Diabetes Mellitus: An Epigenome-Wide Association Study of DNA Methylation in the Korean Genome and Epidemiology Study.

Seo H, Park J, Hwang J, Choi H, Park S, Lee J Genes (Basel). 2023; 14(12).

PMID: 38137029 PMC: 10743302. DOI: 10.3390/genes14122207.


An Assessment of MT1A (rs11076161), MT2A (rs28366003) and MT1L (rs10636) Gene Polymorphisms and MT2 Concentration in Women with Endometrial Pathologies.

Michalczyk K, Kapczuk P, Witczak G, Tousty P, Bosiacki M, Kurzawski M Genes (Basel). 2023; 14(3).

PMID: 36981043 PMC: 10048541. DOI: 10.3390/genes14030773.


A Study to Investigate the Role of Noncoding RNA miR146 Alpha as a Potential Biomarker in Prostate Cancer.

Worthington M, Aurelus C, Banerjee N, Krauss C, Kahan W, Banerjee S J Anal Oncol. 2022; 11:21-23.

PMID: 36540895 PMC: 9762859. DOI: 10.30683/1927-7229.2022.11.03.


Genetic and Epigenetic Regulation of Brain Organoids.

Wang Y, Hu N, Li X Front Cell Dev Biol. 2022; 10:948818.

PMID: 35846370 PMC: 9283755. DOI: 10.3389/fcell.2022.948818.


References
1.
Kim M, Lee J, Oh T, Moon Y, Chang E, Seo K . Genome-wide identification of OTP gene as a novel methylation marker of breast cancer. Oncol Rep. 2012; 27(5):1681-8. DOI: 10.3892/or.2012.1691. View

2.
Wei J, Haddad A, Wu K, Zhao H, Kapur P, Zhang Z . A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015; 6:8699. PMC: 4846314. DOI: 10.1038/ncomms9699. View

3.
. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014; 159(3):676-90. PMC: 4243044. DOI: 10.1016/j.cell.2014.09.050. View

4.
Tsai P, Huang S, Tsai H, Ma C, Hou M, Yang I . The association between DNA copy number aberrations at chromosome 5q22 and gastric cancer. PLoS One. 2014; 9(9):e106624. PMC: 4161348. DOI: 10.1371/journal.pone.0106624. View

5.
Verma M, Rogers S, Divi R, Schully S, Nelson S, Su L . Epigenetic research in cancer epidemiology: trends, opportunities, and challenges. Cancer Epidemiol Biomarkers Prev. 2013; 23(2):223-33. PMC: 3925982. DOI: 10.1158/1055-9965.EPI-13-0573. View